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Abstract
Extracellular ATP, when added as a single dose at concentrations higher than 0.1 mM to the culture medium, was growth
inhibitory or even cytotoxic for human epidermoid carcinoma cells (A431). Adenosine at the same concentrations was much
less potent. The molecular mechanism underlying the inhibitory effect of extracellular ATP has been investigated. The
cytostatic as well as the cytotoxic effects of ATP could be prevented by supplying uridine as a pyrimidine source and,
alternatively, by simultaneous addition of dipyridamole, which inhibits the uptake of adenosine. The data suggest that the
long-term production and continuous uptake of adenosine, which is enzymatically generated from the ATP in the medium,
led to an intracellular nucleotide imbalance with pyrimidine starvation. This triggered suicidal processes ending up in
apoptosis of the cells. The tumor cells have been adapted to extracellular ATP with the aim to obtain cells which are more
resistant to ATP. Therefore, growing cells were periodically treated with extracellular ATP. These cells were characterized by
an enlargement of cell size, a decreased proliferation rate, and a reduced but not abolished sensitivity to cytostatic and
cytotoxic ATP doses. The calcium response of adapted cells was shortened. The nucleotide hydrolyzing ectoenzyme activities
(ecto-ATPase, ecto-ADPase, ecto-AMPase, ecto-Ap4Aase) were simultaneously upregulated. All phenotypic alterations of
the adapted cells disappeared after cultivation for several generations in the absence of extracellular ATP. Considering ATP
as a potential chemotherapeutic agent the adaptive phenomena of treated cells might be important. 0167-4889 / 98 / $ ^ see
front matter ß 1998 Published by Elsevier Science B.V. All rights reserved.
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1. Introduction
Extracellular adenosine triphosphate (ATP) has
been reported to exhibit anticancer activity in vivo
when injected intraperitoneally into tumor bearing
animals [1^3]. Based on those animal model studies,
the ¢rst clinical trials with cancer patients have been
initiated [4]. The molecular basis of the in vivo tumor
growth inhibition by extracellular ATP is still not
fully understood.
A variety of in vitro studies on the e¡ect of extra-
cellular ATP in several transformed and non-trans-
formed cells revealed controversial results. In some
cell systems extracellular ATP at low concentrations
was mitogenic [5^9]. In combination with other
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known mitogens, ATP synergistically displayed
growth stimulation. These stimulatory e¡ects of
ATP were probably mediated by P2-purinoceptors
in the cell membrane which initiate signaling cas-
cades involving the activation of early growth re-
sponse genes such as Egr-1 [10^14].
However, extracellular ATP at higher concentra-
tions displayed cytostatic as well as cytotoxic e¡ects
in a variety of cell systems, especially tumor cells [15^
20]. Several mechanisms of ATP-mediated cytotoxic-
ity have been discussed. Cells of the monocytic/mac-
rophage lineage express P2z-purinoceptors, recently
identi¢ed as a P2x7 receptor by Suprenant et al.
[21], that form large pores across the cytoplasmic
membrane after ligand binding [22,23]. Other cells,
like ¢broblasts, are inhibited by extracellular ATP
through the continuous generation of adenosine
from ATP via the action of extracellular as well as
membrane-bound nucleotidases [3,24,25]. Cytotoxic
T-lymphocytes (CTL) are characterized by extraordi-
narily active ecto-ATPases and are almost insensitive
to extracellular ATP by protection through rapid
ATP hydrolysis [26,27].
In this study, we have delineated the growth inhib-
itory and cytotoxic e¡ect of ATP in the human epi-
dermoid cell line A431. We attempted to culture less
sensitive and, if possible, resistant A431 tumor cells
by periodical addition of ATP into the culture me-
dium. Several features of the cells including cell mor-
phology, proliferation rate, Ca2 response and the
activities of membrane bound ectonucleotidases
have been characterized and observed during the
process of adaptation to cytostatic ATP in the me-
dium.
2. Materials and methods
2.1. Materials
[2-3H]AMP (14 Ci/mmol), [2-3H]ADP (18 Ci/
mmol), [14C]ATP (50 Ci/mmol) and [2,8-3H]Ap4A
(51 mCi/mmol) were from Amersham International.
Dimethylsulfoxide (DMSO) and thin-layer plastic
sheets coated with PEI-cellulose were obtained from
Merck (Darmstadt, Germany).
Tissue culture plastics were obtained from Nunc
(Wiesbaden, Germany). Fetal calf serum (FCS), tryp-
sin (2.5%), RPMI 1640 medium were obtained from
Gibco Life Technologies (Eggenstein, Germany),
Fura-2/acetoxymethyl ester and ionomycin from Cal-
biochem (Bad Soden, Germany). Pyruvate, NAD
and NADH were from Boehringer (Mannheim, Ger-
many). Terminal deoxynucleotidyl transferase (TdT
enzyme) and working solutions for the DNA frag-
mentation (apoptosis) assay were purchased from
Oncor (Gaithersburg, USA).
All other reagents and materials were purchased
from Sigma (Deisenhofen, Germany).
2.2. Cell culture, cell proliferation
Human epidermoid carcinoma cells A431, ob-
tained from the American Type Culture Center
(CRL 1555, Rockville, USA), were cultured in
RPMI 1640 containing 10% FCS, 2 mM glutamine
and antibiotics (100 units/ml penicillin and 50 Wg/ml
streptomycin) at 37‡C in humidi¢ed air with 5%
CO2. Cultures were seeded at 6U103/cm2 and grown
in 90 mm Petri dishes to con£uence.
Cell proliferation kinetics were determined in
24-well plates after seeding 5U103^6U104 cells/well
in 2 ml of medium. Viability of cells, after addition
of nucleotides or other agents, was checked by har-
vesting the A431 cultures at designated times. The
cell suspensions obtained after trypsinization were
incubated with trypan blue dye to distinguish dead
from viable cells in a Fuchs-Rosenthal counting
chamber. Cell proliferation was alternatively meas-
ured by an electronical counter system (CASY1,
Scha«rfe System, Germany). Human promyelocytic
leukemia cells, HL60, were from the Max Planck
Institute (Erlangen, Germany). These cells were
grown in cell suspension under the same cultivation
conditions described for A431 cells.
2.3. Protein measurement
Protein measurement followed the protocol of the
Bio-Rad procedure (Bio-Rad, Munich, Germany).
Alternatively, cell lysates were prepared by adding
NaOH to the washed cell layers in the growing
dishes. The protein content in 100 Wl aliquots was
determined with the method of Bradford [28].
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2.4. Lactate dehydrogenase activity
Lactate dehydrogenase activity (EC 1.1.1.27) in the
culture medium was determined as an indicator of
cell damage. One unit catalyzes the oxidation of
1 Wmol NADH/min. The values obtained were com-
pared with the activities measured in total cell ly-
sates, which were taken as 100%. The assay was per-
formed at 25‡C in a total volume of 1 ml: 750 Wl
phosphate bu¡er (0.1 M, pH 7.4), 25 Wl NADH
(0.01 M) and 200 Wl of sample under investigation.
The reaction was initiated with 25 Wl pyruvate (0.1 M)
[29].
LDH release of cells in long-term cultures was
determined by the method of Decker and Loh-
mann-Matthes [30]. In brief, 2U104 cells were seeded
in 96-well plates. Twenty-four hours later, nucleo-
tides or other agents were given in 100 Wl of medium
containing 3% FCS. LDH, together with diaphorase-
FAD converts p-iodonitrotetrazolium (INT) into a
formazan product, which was measured at 490 nm.
In the culture of cells treated with ATP, the LDH
content could not be measured using this method
due to interference of the reaction with the nucleo-
tide. In those experiments LDH was measured only
in the lysate. The cells seeded in 96-well plates
were treated with 150 Wl 0.1% Triton X-100 in
medium containing 3% FCS. After 3 min, 20 Wl of
400 mM lactate (in 10 mM Tris-HCl, pH 8.5) and
20 Wl of 4 mM INT (in PBS) were added. The reac-
tion was initiated by adding 20 Wl of NAD-diapho-
rase-FAD solution (NAD 3 mg/ml; diaphorase-
FAD 13.5 U/ml; BSA 0.03%) and stopped after
20 min with 20 Wl of 186 mM oxamate. The extinc-
tion di¡erence at 490 nm was measured after 20
min.
2.5. Assay of nucleotide metabolism by cellular
ectoenzymes (thin-layer technique)
In order to measure membrane-bound nucleotide
metabolizing enzyme activities, cells were grown in
96-well plates to con£uence. The supernatant was
removed and, after two washings with HBSS bu¡er
(Hanks’ bu¡ered salt solution), the cells were over-
laid with 80 Wl of HBSS bu¡er containing radioac-
tively labeled nucleotide at a starting concentration
given in parentheses: [14C]ATP (12 WM), [2-3H]AMP
(1.2 WM), [2-3H]ADP (1.4 WM), and [2,8-3H]Ap4A
(1.8 WM).
Three Wl of cell culture supernatants were directly
spotted on PEI-cellulose thin-layer sheets, a proce-
dure that was found to interrupt all enzymatic reac-
tions within less than 30 s [31]. A mixture of marker
nucleotides was added to each starting point of the
layer. Separation was achieved with water and, after
drying, with 0.85 M LiCl at room temperature. After
drying the plates, the nucleotides were marked under
ultraviolet light and cut o¡. The thin-layer pieces
were counted in a scintillation mixture (toluene,
0.5% PPO (2,5-diphenyloxazole), 0.03% dimethyl-
POPOP [1,4-bis(4-methyl-5-phenyloxazol-2-yl)ben-
zene]).
Protein concentrations of con£uent A431 mono-
layers in 96-well plates were found to be nearly iden-
tical independent of the pretreatment of the cells
forming the monolayer. For this reason, cell surface
ectoenzyme activity was related to protein content of
total cell lysates.
2.6. Measurement of glutathione
Glutathione (GSH) was measured enzymatically
according to Tietze [32] and modi¢ed for our pur-
poses. In principle, GSH is stoichiometrically oxi-
dized to GSSG while the colored thionitrobenzoate
(TNB) is formed from the colorless dithionitroben-
zoic acid (DTNB). The reaction is accelerated by a
recycling process with glutathione reductase (GR)
which regenerates GSH from GSSG. The absorbance
of the product at 412 nm is proportional to the GSH
content of the sample.
Cells were seeded in 24-well plates. At various time
points after the addition of nucleotides, the super-
natant (500 Wl HBSS) was completely removed, and
the cells were lysed with 0.1% Triton X-100 in HBSS.
The following steps were performed at 4‡C to mini-
mize autoxidation of GSH. To 500 Wl of samples,
100 Wl 20% sulfosalicylic acid were added for protein
precipitation. The samples were then centrifuged,
and 120 Wl 20% triethanolamine were added to the
remaining supernatant for neutralization. Five hun-
dred Wl of 10 mM DTNB in bu¡er A (100 mM
K2HPO4 and 17.5 mM Na2EDTA, pH 7.5) were
then added. For the purpose of measuring the cata-
lytic reaction, 50 Wl aliquots of the sample mixture
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were incubated with 500 Wl glutathione reductase
(14 U/ml) at room temperature. The reaction was
started by the addition of 0.4 WM NADPH in bu¡er
B (100 mM K2HPO4, 5 mM Na2EDTA, pH 7.5). The
continuously generated product TNB was measured
at 412 nm with a spectral photometer (UV-210A
Shimadzu) over a period of 3 min. The concentration
of GSH was calculated using a standard curve ob-
tained from variable concentrations of GSH in HBSS
containing 0.1% Triton X-100. The sensitivity of the
method allowed the detection of 125 nM GSH.
2.7. Measurement of [Ca2+]i in intact cells
Free intracellular Ca2 was measured using the
£uorescent indicator Fura-2/AM as described by
Treves et al. [33]. In brief, 107 A431 cells were trypsi-
nized, centrifuged and resuspended in 1 ml RPMI
containing 10% FCS. While shaking gently, 4 Wl
Fura-2/AM (1 mg/ml DMSO at a ¢nal concentration
of 4 WM) were added to the cells. After incubation
for 15 min at 37‡C, the cell suspension was diluted
1/5, washed once after centrifugation (300Ug), and
resuspended after one further centrifugation in 6 ml
medium for measurement (140 mM NaCl, 5 mM
KCl, 1 mM MgSO4, 1 mM CaCl2, 20 mM HEPES,
1 mM NaH2PO4, and 5.5 mM glucose, pH 7.4).
Fluorescence in a 2 ml cell suspension was deter-
mined in a LS-3B £uorometer (Perkin-Elmer)
equipped with a chart recorder. Excitation wave-
length was 340 nm, emission wavelength 510 nm.
All measurements were carried out at room temper-
ature. Maximal £uorescence (Fmax) was determined
by the addition of 2 Wl ionomycin (2 WM) or 0.1%
Triton X-100. Minimal £uorescence (Fmin) was deter-
mined by the addition of 20 Wl EGTA/Tris (4 mM
EGTA and 40 mM Tris as f.c. ; pH 7.4).
[Ca2]i concentration was calculated from the for-
mula [Ca2]i = Kd [(F3Fmin)/(Fmax3F)], where F is
£uorescence, and Kd (224 nM) the dissociation con-
stant [34].
2.8. Apoptosis
2.8.1. DNA fragmentation by oligonucleosome ladder
display
Cells were harvested 8^24 h after application of
nucleotides or agents, which were added to con£uent
cultures in medium containing 10% FCS. Cells were
washed with PBS twice and lysed with 1% Triton
X-100 in bu¡er containing 10 mM HEPES (pH
7.4), 1.5 mM MgCl2, 10 mM CaCl2 and 0.5 mM
L-mercaptoethanol. After a 1 h incubation with
0.1 mM EDTA (pH 8.0) and 0.2% SDS, proteinase
K (300 Wg/ml) was added. The reaction mixture was
further incubated at 50‡C for 5 h.
Subsequently, a triple extraction of DNA with
phenol (saturated with 100 mM Tris-HCl bu¡er,
pH 7.4) was performed. The ¢nal precipitation of
DNA in the aqueous phase was obtained by adding
equal amounts of isopropanol and 0.1 vol. of sodium
acetate. Following centrifugation, ice cold ethanol
(70%) was added. The DNA precipitate was dis-
solved in 10 mM Tris-HCl (pH 8.0) and 0.1 mM
EDTA and then digested with RNase A for 30 min
at 37‡C (200 Wg/ml). After addition of ethanol
(100%) and further centrifugation, DNA was washed
once again with ethanol, and the sample was then
dissolved in TE bu¡er.
Ten Wg of DNA were analyzed on a 1% agarose
gel containing ethidium bromide by electrophoresis
in TBE bu¡er. As a standard, DNA from xX174
(HAE III) was used.
2.8.2. Assay of in situ fragmentation by end-labeling
with digoxigenin-UTP and terminal transferase
(TUNEL assay)
A431 cells were cultured on poly-L-lysine-coated
glass coverslips and incubated with nucleotides or
agents from 8 to 24 h. At di¡erent time points,
the coverslip cultures were washed once and treated
with 0.01% Triton X-100 in PBS (pH 7.4) for
15 min. In situ analysis of DNA fragmentation
was performed by a modi¢ed method as described
earlier by Gavrieli et al. [35], using end-labeling of
nicked DNA with digoxigenin-nucleotide (UTP),
which is enzymatically added to the DNA by termi-
nal deoxynucleotidyl transferase (TdT). A secondary
reaction with £uorescein-labeled anti-digoxigenin
antibody and counterstaining of the cells with pro-
pidium iodide (0.25 Wg/ml) was applied to visualize
the incorporated nucleotide. Microscopic visualiza-
tion was performed with a Zeiss £uorescence micro-
scope.
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2.9. Adaptation of A431 to extracellular ATP
The treatment protocols were as follows.
2.9.1. Protocol A: repeated treatments with ATP at a
constant concentration
A431 cells (106) were seeded into 90 mm plastic
dishes. On the following day, one dish was treated
with 0.5 mM ATP, another dish with 2 mM ATP.
Growth behavior of the cells was monitored optically
by phase-contrast microscopy. Once a con£uence of
about 50% was reached (i.e. after 4^8 days), a second
dose of ATP was added at the same concentration as
the ¢rst one (0.5 mM; 2 mM). Cells treated with
0.5 mM ATP showed a reduction in cell number
within the ¢rst 2 days but then started to proliferate
again. Five to 6 days after the second ATP applica-
tion, a third ATP treatment followed. In this manner
ATP was given on every ¢fth to sixth day up to a
total number of ten ATP treatments. The obtained
cells were designated mcATP(0.5) (multiple, con-
stant ATP treatment with 0.5 mM). The cell culture
medium (RPMI containing 10% FCS) was changed
every second day, the cells were trypsinized and
seeded into 90 mm plastic dishes after reaching con-
£uence. Cells treated with 2 mM ATP reacted with
drastic cell loss within the ¢rst 4 days after applica-
tion and needed about 8 days to obtain 50% con£u-
ence again. At this point, the third ATP treatment
was given. In this way, ATP was given to the cells up
to a total number of ten applications. The time in-
tervals between the cycles of applications were 6^8
days. The obtained cells were designated
mcATP(2.0) (multiple, constant ATP treatment
with 2.0 mM). After the tenth ATP application
(0.5 mM; 2 mM), one part of the cells was treated
with ATP for another 5 times as described above, the
other part was cultured without further ATP appli-
cations.
2.9.2. Protocol B: repeated treatments with ATP at
increasing concentrations
A431 cells (106) were seeded in 90 mm dishes, and
0.1 mM ATP was added to the culture medium when
cells had reached 50% con£uence (designated as day
1 of ATP treatment). One day after that (day 2 of
ATP treatment), 0.1 mM ATP was added, on day 3
the ATP concentration was increased to 0.2 mM and
this concentration was given again on day 4. In this
way, every day, regardless of the con£uence of the
cells, ATP was added. The concentration was in-
creased in 0.1 mM steps and each dose was given
twice. At a maximal dose of 0.4 mM ATP (day 7
of ATP treatment), the treatment was repeated in
3 day intervals. In this way, the applied dose was
increased up to 0.7 mM ATP with every dose given
twice to the cells. Total number of ATP applications
was 13 at that point. The obtained cells were desig-
nated miATP (multiple, increasing concentrations of
ATP during treatment). During the treatment proto-
col, several dishes were taken out at di¡erent time
points and cultured without further ATP treatment.
2.9.3. Protocol C: repeated treatment with ATP at
subinhibitory concentrations
A431 cells (106) were seeded in 90 mm Petri dishes
and treated with 70 WM ATP at a state of 50% con-
£uence (day 1 of ATP treatment). On every second
day, 70 WM ATP was given again into the culture
medium up to a total number of ten ATP applica-
tions which were reached at day 19 after the ¢rst
ATP treatment. The obtained cells were designated
msiATP (multiple, subinhibitory concentrations of
ATP).
3. Results
Extracellular ATP at millimolar concentrations
can inhibit cell growth and may be toxic. Several
reports have described transformed cells to be more
sensitive than their non-transformed counterparts
[15,36]. In our study we used the human epidermoid
carcinoma cell line A431, which has been reported to
respond to ATP at concentrations lower than 0.1 mM
with increased mitogenic activity [6,10]. Higher con-
centrations of ATP lead to growth inhibition. The
aim of this study was to select ATP-resistant or
adapted cells, and to highlight the role of nucleotide
metabolizing ectoenzyme activities.
3.1. Cytostatic and cytotoxic e¡ects of ATP
3.1.1. Cell proliferation
After application of ATP into the culture medium
as a single dose, A431 responded di¡erently depend-
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ing on the concentration of the nucleotide. ATP at
concentrations of 0.1^0.3 mM led to a transient re-
tardation of cell proliferation. After 1^2 days, the
growth rate recovered. Extracellular ATP at 0.4^1
mM triggered a long-term growth inhibitory e¡ect
with no net cell proliferation, referred to as cytostatic
e¡ect. Higher concentrations resulted in cell damage
and cell loss in the culture. Determination of cell
numbers on day 4 after a single dose of ATP was
taken to calculate the dose-response curve in com-
parison to control growth (Fig. 1). Inhibition of pro-
liferation started at about 0.08 mM, 50% of inhibi-
tion (ED50) was reached at 0.3 mM ATP.
Nucleotide speci¢city testing revealed that all pu-
rine nucleotides and also adenosine (Ado) inhibited
cell proliferation (calculated as growth relative to
control on day 4 after a single treatment with
0.5 mM nucleotide). The adenine nucleotides AMP
(28.6% þ 5.0), ADP (30.2% þ 5.4) and ATP
(33.6% þ 7.6) were highly inhibitory. The degradation
product adenosine a¡ected the proliferation rate of
A431 cells to a signi¢cantly lower extent
(68.1 þ 4.3%).
3.1.2. Lactate dehydrogenase release
The release of lactate dehydrogenase (LDH; 140
kDa) was measured as an indicator of lytic cell dam-
age. When applying the classical enzymatic method
of Vassault [29], within 1 h after addition of even
high concentrations of ATP (up to 4 mM) no signi¢-
cant LDH release was detectable (data not shown).
When following the LDH contents in cellular ly-
sates instead of measuring LDH release into the me-
dium over 2 days after ATP treatment, a gradual loss
was measurable, which, however, paralleled the loss
of cell numbers in the cultures treated with 2 and
4 mM ATP. Two mM ATP led to 54% ( þ 8.0)
LDH loss after 45 h, 4 mM ATP to 65% ( þ 11.2).
3.1.3. Glutathione release
Permeabilization of the cell membrane immedi-
ately after the addition of ATP with a pore forma-
tion for molecules smaller than 20 kDa via the P2x7
receptor (formerly called P2z receptor) has been
postulated to be one mechanism of ATP cytotoxicity
in several cell lines [23,37,38]. Therefore, we meas-
ured the loss of intracellular glutathione (GSH;
613 Da) over a period of 60 min after ATP addition
to A431 cells. Intracellular GSH content of control
cells was 5 nmol per 106 cells. No loss of intracellular
glutathione was detectable within 60 min after the
addition of 2 mM ATP into the culture medium
suggesting that an ATP-mediated toxicity is probably
not initiated by a pore formation leading to a loss of
small intracellular metabolites. The data do not ex-
clude the existence of a P2x7 receptor in A431 cells
since the concentration of ATP43 in the applied me-
dium has not been determined.
3.2. Apoptosis triggered by extracellular ATP
A431 cells were grown to con£uence and then
treated with ATP (0.5^6 mM) for 8^24 h. Agarose
gel electrophoresis of extracted DNA showed a lad-
der pattern of endonucleolytic DNA degradation
products in cells treated with ATP concentrations
in the range of 0.5^2 mM, indicating apoptotic cell
death. Higher concentrations (4^6 mM ATP) led to a
smear-like pattern implicating a necrotic or lytic cell
death (Fig. 2a).
ATP-induced apoptosis in A431 was con¢rmed
with the TUNEL assay. Spontaneous apoptosis in
untreated control or adapted cells could hardly be
detected (Fig. 2b). After ATP application at concen-
trations of 0.5^2 mM for 24 h the £uorescence dis-
tribution in the nuclei showed the typical pattern of
Fig. 1. Growth inhibition of A431 cells treated with a single
dose of ATP at variable concentrations. When the cells had
reached adherence about 8 h after seeding, ATP was added to
the culture medium. The dose-response curve was determined
by cell counting on day 4 after the addition of ATP. The num-
ber of cells in untreated (control) cultures was set at 100%. The
threshold concentration of ATP for inhibition was about 0.08
mM, 50% of inhibition (ED50) was reached at about 0.3 mM.
Results are expressed as mean þ S.E.M. (n = 4).
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Fig. 2. (a) Oligonucleosomal ladder formation of DNA extracted from con£uent cells treated with ATP or Ara-C. Agarose gel electro-
phoresis of DNA extracted from untreated A431 cells (lane 2), and from cells treated with variable concentrations of ATP for 8 h
(lane 4, 0.5 mM; lane 5, 1 mM; lane 6, 2 mM ATP). Lane 7, A431 cells treated with 10 WM Ara-C for 8 h; lane 3, HL-60 cells
treated with 10 WM Ara-C for 8 h (described by Sen and D’Incalci [68] to induce apoptosis). Lane 1, DNA standard xX174 (72 bp^
1353 kb). DNA was extracted as described in Section 2 and loaded on the gel (10 Wg per lane). Visualization was performed by UV il-
lumination after reaction with ethidium bromide. (b^d) In situ assay of DNA fragmentation by the end-labeling technique (TUNEL
assay). (b) Untreated A431 control cells. (c) A431 cells were incubated with 1 mM ATP for 24 h and processed as described in Sec-
tion 2. (d) ATP-adapted cells (mcATP(2.0)) after eight cycles of ATP treatment incubated with 1 mM ATP for 24 h.
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increased endonuclease activity during apoptotic cell
death [35,39] (Fig. 2c). Cells adapted to ATP by pe-
riodical treatment cycles with this nucleotide still
showed DNA fragmentation and apoptotic £uores-
cence distribution (determined by gel electrophoresis
and TUNEL assay respectively) following ATP given
Fig. 3. Degradation of ATP by ectoenzymes of intact A431 cells growing as a monolayer in culture dishes. Control cells, and cells
gained from adaptation procedures (mcATP(0.5), mcATP(2.0), miATP), were grown in 96-well plates to con£uency (2^5 days after
the ¢fth addition of ATP to the medium). After washing the monolayers, the cells were overlaid with 80 Wl of HBSS bu¡er containing
[14C]ATP at a ¢nal concentration of 12 WM. The kinetics of ATP degradation, and the accumulation of the hydrolysis products
(ADP, AMP, adenosine) in the extracellular milieu were determined by the thin-layer technique as described in Section 2. Protein con-
centration was assessed in total cellular lysates and used for calibration.
Table 1
Catabolism of ATP in A431 cells adapted to ATP
A431 mcATP(0.5) mcATP(2.0) miATP
ATP hydrolysis initial rate (nmol/minUmg protein) 1.50 þ 0.47 (n = 7) 2.60 þ 0.35 (n = 3) 5.19 þ 0.60 (n = 3) 6.23 þ 1.33 (n = 2)
ATP hydrolysis (relative capacity) 1.0 1.7 3.5 4.2
Rate of ATP hydrolysis by ecto-ATPase in A431 cells. The protocols for adaptation (mcATP, miATP) are described in Section 2.
Cells were taken after ¢ve cycles of ATP treatment and processed as noted in the legend of Fig. 3. Initial velocities of ATP hydrolysis
were determined and expressed as nmol per min and mg protein. Data are given as mean þ S.E.M. (n = 2^7).
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into the culture medium (concentration 0.5^2 mM)
(Fig. 2d). This suggests that adapted cells had not
lost the apoptotic response to ATP.
3.3. Membrane-bound nucleotide hydrolyzing
activities (ectonucleotidases)
3.3.1. Membrane-bound nucleotide hydrolyzing
activities of A431 cells and ATP-adapted
cells (ectonucleotidases)
A431 cells express membrane-bound ectoenzymes
which hydrolyze extracellular ATP, ADP, AMP, and
the dinucleotide Ap4A, with activities very similar to
bovine endothelial cells described earlier [31]. The
enzymes were tentatively named ‘ecto-ATPase’,
‘ecto-ADPase’, ‘ecto-AMPase’, and ‘ecto-Ap4Aase’,
respectively.
ADP at 1.4 WM was metabolized by an ecto-ADP-
ase to AMP and by a ‘5P-nucleotidase’ further to
adenosine, without detectable amounts of generated
ATP. An adenylate kinase activity could not be
measured at this low ADP concentrations. AMP at
1.2 WM generated only adenosine as the expected
metabolite by an ecto-AMPase (5P-nucleotidase) ac-
tivity. Metabolism of dinucleotides as determined
with Ap4A as substrate is characterized by an asym-
metrical cleavage generating AMP plus ATP as prod-
ucts [31]. At a substrate concentration of 1.8 WM,
Ap4A was metabolized with a relatively slow kinetic
by an ectodinucleotidase (Ap4Aase). Over a period
of 120 min, no metabolite products were accumu-
lated in the medium. This was due to a faster further
metabolization of the primary products ATP, ADP
and AMP and ¢nally uptake of adenosine.
All ATP-adapted cells (mcATP(0.5), mcATP(2.0)
and miATP) were characterized by increased ecto-
ATPase activities (Fig. 3, Table 1). The initial rate
of ATP hydrolysis, expressed as nmol/minUmg pro-
tein, was accelerated 1.7-fold (mcATP(0.5)), 3.5-fold
(mcATP(2.0)) and 4.2-fold (miATP). All adapted
cells had been treated with ¢ve cycles of ATP at
time point of measurement.
However, the pattern of accumulated products
during the time course of ATP degradation varied
among the adapted cultures (Fig. 3). Whereas con-
trol cells predominantly accumulated ADP (28% of
the initial substrate concentration) and AMP (up to
18% within 30 min after substrate application) (Fig.
3a), the ATP-adapted cells showed a rapid accumu-
lation of AMP, but almost no ADP within this time.
In mcATP(2.0) cells, the AMP concentration
reached a peak of 54% of the initial substrate con-
centration within 30 min (Fig. 3c). It is assumed that
ADP was formed but rapidly split into AMP by the
simultaneously activated ecto-ADPase, rather than
considering the activity of an ATP-pyrophosphory-
lase with AMP as the initial product. ADP did not
accumulate (6.6% at 6 min and 5.5% at 30 min). The
miATP cells showed nearly the same kinetics (AMP
peaked up to 40%, ADP reached 8% of the initial
substrate concentration at 30 min) (Fig. 3d). Accord-
ing to the relatively weak increase of ecto-ATPase
activity in mcATP(0.5) cells (compared to
mcATP(2.0) and miATP), a low peak concentration
Table 2
Catabolism of ATP, ADP, AMP and Ap4A respectively in A431 cells adapted to ATP
A431 mcATP(0.5) mcATP(2.0) miATP
ATP hydrolysis, initial rate (nmol/minUmg protein) 1.50 þ 0.47 (n = 7) 2.60 þ 0.35 (n = 3) 5.19 þ 0.60 (n = 3) 6.23 þ 1.33 (n = 2)
(1.0) (1.7) (3.5) (4.2)
ADP hydrolysis, initial rate (nmol/minUmg protein) 0.11 þ 0.01 (n = 2) 0.30 þ 0.02 (n = 2) 0.72 þ 0.06 (n = 2) 0.88 þ 0.06 (n = 2)
(1.0) (2.7) (6.5) (8.0)
AMP hydrolysis, initial rate (nmol/minUmg protein) 0.13 þ 0.03 (n = 3) 0.23 þ 0.02 (n = 2) 0.35 þ 0.02 (n = 2) 0.67 þ 0.06 (n = 2)
(1.0) (1.7) (2.6) (5.0)
Ap4A hydrolysis, initial rate (nmol/minUmg protein) 0.009 (n = 1) 0.091 (n = 1) 0.186 (n = 1) n.d.
(1.0) (1.9) (3.8)
Rate of hydrolysis of ATP, ADP, AMP and Ap4A in A431 cells treated with di¡erent protocols for adaptation. Cells were taken after
¢ve cycles of ATP treatment. Initial velocities of substrate hydrolysis were derived from graphs obtained similar to Fig. 4, and ex-
pressed as nmol per min and mg protein. Bolded values in parentheses express the relative capacity of hydrolysis in comparison to
control. Data are given as mean þ S.E.M. (n = 1^7). n.d., not determined.
BBAMCR 14315 4-9-98
H.S. Wiendl et al. / Biochimica et Biophysica Acta 14315 (1998) 282^298290
of AMP within 30 min was found (23%). ADP con-
centration at 30 min was 14.5% of the initial sub-
strate concentration (Fig. 3b).
The initial rate of adenosine accumulation was low
in control cells, but much higher in the ATP-adapted
cells.
ADP, AMP and dinucleotide metabolism (meas-
ured with Ap4A) were simultaneously activated
(Fig. 4, Table 2). All measured nucleotide metaboliz-
ing enzymes (ecto-ATPase, ecto-ADPase, ecto-AMP-
ase, ecto-Ap4Aase) were stimulated by recurrent
treatment of A431 cells with ATP at cytostatic or
cytotoxic concentrations. Metabolism of ADP was
stimulated most prominently (Fig. 4b), increasing
the initial rate of substrate hydrolysis 2.7-fold
(mcATP(0.5)), 6.5-fold (mcATP(2.0)) and 8-fold
(miATP cells).
In summary, the miATP cells exhibited the most
dramatic increase in all measured enzyme activities.
With those cells, ATP had been given more fre-
quently but in lower concentrations to the cells.
The mcATP(2.0) cells showed a higher activation
of ectonucleotidases than the mcATP(0.5) cells.
With these cells, adaptation to ATP had been ac-
Fig. 4. Degradation of ATP, ADP, AMP, and Ap4A, respectively, by ectoenzymes of intact cells growing as a monolayer. Control
cells, and cells gained from adaptation procedures (mcATP(0.5), mcATP(2.0), miATP), were processed as described in the legend of
Fig. 3 after the ¢fth addition of ATP to the medium. [14C]ATP was given into the supernatant at a ¢nal concentration of 12 WM, [2-
3H]ADP at 1.4 WM, [2-3H]AMP at 1.2 WM, and the dinucleotide [2,8-3H]Ap4A at 1.8 WM. The kinetics of substrate metabolism were
determined by the thin-layer technique as described in Section 2.
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quired by recurrent cycles at constant concentrations
of 0.5 and 2 mM respectively.
Ectoenzyme activities were measured and followed
during the adaptation process of cells. After two
cycles of ATP applications as shown with the
mcATP(2.0) cells, the initial rate of ATP hydrolysis
was doubled (2.1-fold) and increased up to 7.6-fold
velocity (after ten cycles of ATP applications). The
increased activities reached an endpoint, and further
applications of ATP did not alter this activity mark-
edly. Our data for cells treated more frequently but
with lower and increasing concentrations (miATP
cells) revealed similar results: at a ¢nal concentration
of 0.3 mM of ATP, ecto-ATPase activity was
4.5-fold increased, at 0.5 mM the activity reached
its endpoint with 11.2-fold increase. Further ATP
applications did not alter this activity signi¢cantly
(10.5-fold increase at 0.7 mM ATP).
The described alterations of ectoenzymes were re-
versible and the activities returned to control levels
within 3 weeks when culturing the cells without fur-
ther ATP applications. Thus, the phenomenon of
enzyme adaptation was completely reversible.
3.3.2. Kinetic characterization of increased ecto-
ATPase activity
To clarify the molecular mechanism of increased
enzyme activity, enzyme kinetics for the substrate
ATP were performed to determine the Michaelis-
Menten constant (Km) and the maximal velocity
(Vmax). The Km for ATP was 437 WM for A431 con-
trol cells and 569 WM for miATP cells. However, the
Vmax (calculated from a Lineweaver-Burk plot) was
clearly increased in miATP cells from 62 Wmol/min
U105 cells (A431 control cells) up to 284 Wmol/min
U105 cells.
3.3.3. E¡ect of subinhibitory concentrations of ATP
Subinhibitory concentrations of ATP (70 WM) re-
currently given to A431 cells (msiATP) did not alter
the ectoenzyme activities of the cells (data not
shown).
3.4. Morphology of A431 cells during the process of
adaptation
A431 cells were epithelioid-shaped and did not
show morphological changes during cultivation
over several passages (s 30). During the recurrent
treatment of A431 with inhibitory concentrations of
ATP, cells altered morphologically, as followed by
phase-contrast microscopy. The surviving cells were
enlarged and seemed £attened. Some of them had
pseudopodia (Fig. 5). The morphological changes
became apparent around the ¢fth cycle of ATP treat-
ment. Cells partially lost their adherence and were
more easily detached by a mild trypsin treatment.
As described above for the ectoenzyme activities,
the morphological changes were completely reversi-
ble. Three weeks after the cessation of recurrent ATP
treatments, adapted cells were no more distinguish-
able from A431 control cells by phase-contrast
microscopy.
Fig. 5. (a) Human epithelioid carcinoma cells (A431) in culture.
Phase-contrast microscopic picture (U250). (b) Morphology of
A431 cells treated with 2 mM ATP (mcATP(2.0) cells) as de-
scribed in Section 2. Phase-contrast microscopic picture was
taken after eight cycles of ATP treatment (U250).
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3.5. Calcium response to ATP
A431 cells, which were adapted to extracellular
ATP by periodically repeated treatments with the
nucleotide, clearly di¡ered from control cells in their
Ca2 £uxes after stimulation with 0.1 mM ATP (Fig.
6). Control cells responded with a biphasic Ca2 re-
sponse, which has been described earlier by Gonzalez
et al. [40]. A rapid increase of intracellular free cal-
cium (reaching a peak within seconds) was followed
by a retarded restoration of the calcium level within
6^10 min. This second phase was clearly shortened in
the adapted cells, so that Ca2 returned to base level
within 4^6 min.
3.6. Cell proliferation and the inhibition by ATP
during the adaptation to extracellular ATP
A431 cells, which were recurrently treated with
ATP, slowed down their normal population doubling
time. The estimated population doubling time in-
creased during ATP treatment from less than 1 day
up to several days. After cessation of ATP treatment,
the control rate was reached again within 3 weeks (at
this point, cells were also no longer distinguishable
from control cells by phase-contrast microscopy).
Growth inhibition by ATP (0.5, 2 mM) during the
adaptation process was determined. The extent of
growth inhibition (calculated as percentage of con-
trol growth on day 4 after the addition of ATP to the
culture medium) steadily decreased (i.e. resistance in-
creased) with the number of ATP additions during
the adaptation process (Table 3). However, the con-
tinuation of the protocol was ¢nally limited since the
proliferation rate of those cells continuously de-
creased during the adaptation. Therefore, it was
not possible to select cells with a complete resistance
to ATP by this protocol.
Fig. 6. E¡ect of a single dose (0.1 mM) of ATP on intracellular Ca2 concentration in A431 cells (b), and in cells treated recurrently
with ATP (mcATP(2.0)) (a). Preparation of cell suspensions and loading with Fura-2 was performed as described in Section 2. The
shown recordings are representative of consistently reproducible calcium kinetics gained from several independent experiments. (b)
The [Ca2]i response to ATP in A431 was manifested as a rapid Ca2 increase reaching a peak during 5^10 s (¢rst phase), followed
by a slowly decreasing response (second phase). (a) Cells adapted to repeated ATP treatment (mcATP(2.0)) showed a di¡erent Ca2
response to ATP. The elevation of intracellular Ca2 was signi¢cantly shorter because of a much faster second phase.
Table 3
Increased resistance of A431 cells towards ATP during the course of adaptation to extracellular ATP (A = number of ATP treatments)
A431 control mcATP(2.0) (A = 2) mcATP(2.0) (A = 4) mcATP(2.0) (A = 6) mcATP(2.0) (A = 10)
0.5 mM ATP 17.3 24.8 52.2 48.6 64.9
2 mM ATP 1.6 13.4 18.8 15.6 17.8
Growth inhibition of A431 cells adapted to ATP (mcATP(2.0)) by a single dose of ATP (0.5 and 2 mM) during the adaptation proc-
ess.
Cells were seeded 5 days after the last cycle of treatment. ATP (0.5 mM; 2 mM) was added after the cells had reached adherence.
Cell numbers were determined by counting on day 4 after ATP addition. Control growth was set at 100%. Values are given as mean
of n = 2.
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3.7. Adenosine mediates the cytostatic and cytotoxic
e¡ects of ATP in A431 cells
ATP at cytostatic concentrations was given in the
presence of the nucleoside transport inhibitor dipyri-
damole [41]. The coincubation completely prevented
the growth inhibitory e¡ect of ATP (Fig. 7). Uridine
(50 WM) was capable to completely abolish the
growth retardation in the presence of 0.5 mM ATP
(Fig. 7). The cytostatic e¡ect of increased adenosine
uptake is known to be mediated by a nucleotide im-
balance (pyrimidine starvation) which can be pre-
vented by providing a suitable pyrimidine source
[25,42].
We therefore hypothesize that ATP-mediated cyto-
stasis in A431 is mainly caused by the degradation
product adenosine which is continuously generated
during the metabolism of extracellular ATP.
4. Discussion
When applied as a single dose at concentrations
higher than 0.1 mM, extracellular ATP was shown
to be cytostatic or even cytotoxic for A431 cells. The
data suggest that growth inhibition was mediated by
the long-term generation of adenosine. Inhibition of
adenosine transport by dipyridamole was shown to
completely prevent the cells from ATP toxicity. In
accordance to the results published for transformed
mouse ¢broblasts [24], adenosine when added di-
rectly to the medium exhibited less growth inhibition
than ATP, ADP and AMP at equimolar concentra-
tions. Adenosine is transported into cells via the ad-
enosine translocator [41] and is metabolized by sev-
eral enzymes including adenosine kinase and
adenosine deaminase. Adenosine kinase catalyzes
the formation of intracellular adenine nucleotides.
The continuous uptake of adenosine leads to growth
inhibitory e¡ects by intracellular nucleotide imbalan-
ces and pyrimidine starvation [24,25,43]. This pyrimi-
dine starvation could be prevented by a pyrimidine
source such as uridine.
It seems a paradox that the generation of adeno-
sine is the mechanism of ATP-induced growth inhib-
ition and, on the other hand, a higher rate of ATP
degradation, i.e. a higher rate of adenosine formation
in our ATP-adapted cells, should be the reason for
less growth inhibition. However, in accordance to
our results, adenosine at a higher concentration given
as a single dose is less toxic than adenosine at a low
concentration given continuously over a long time
Fig. 7. Growth inhibition of A431 cells by extracellular ATP (0.5 mM) is prevented by the simultaneous addition of dipyridamole (10
WM), and uridine (50 WM), respectively. Agents were added as a single dose after the cells had reached adherence. The graph shows
data of one experiment, which has been repeated once.
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period [24]. This suggests that a long-lasting e¡ect of
adenosine on the intracellular nucleotide balance is
more critical for growth regulation than a high initial
adenosine concentration which might be counter-
acted by substrate inhibition of the intracellular ad-
enosine kinase [44] or by an accelerated adenosine
deamination yielding inosine, which itself is not
growth inhibitory [45,46]. Whether clustering of cell
surface nucleotidases with the adenosine translocator
might contribute to this paradoxical e¡ect [47], is
also unknown.
No evidence for the formation of large, non-selec-
tive plasma membrane pores following ATP treat-
ment [38,48^51] was found in A431 since the GSH
content of cells was not rapidly altered under our
conditions.
In addition to this lytic cell death mechanism, ex-
tracellular ATP has been implicated as an initiator of
programmed cell death (apoptosis) in thymocytes,
macrophages, lymphocytes and certain tumor cell
lines [19,52,53]. We have shown here that extracellu-
lar ATP at 0.5^2 mM induced DNA fragmentation
in A431 cells after 8^24 h. Condensation of chroma-
tin, fragmentation of the nucleus and the cell were
observed as morphological changes during the pro-
cess of apoptosis in A431. Higher concentrations of
ATP (4^6 mM) induced a smear-like pattern of the
genomic DNA in agarose gels suggesting a lytic or
necrotic cell death mechanism. At these concentra-
tions of ATP, a marked LDH loss occurred within
several hours after nucleotide addition con¢rming a
lytic cell destruction.
For the purpose of selecting ATP-resistant cells,
A431 were recurrently treated with ATP following
di¡erent protocols. During the process of adaptation
towards ATP, cell morphology, growth proliferation,
Ca2 response, and ectonucleotidase activities were
investigated. The di¡erent protocols of ATP applica-
tion led to qualitatively identical results, with growth
inhibition being a prerequisite to induce any adaptive
e¡ects. The adapted cells gained a stepwise reduced
sensitivity towards ATP during the adaptation pro-
cess. At the same time, the proliferation rate of these
cells slowed down from cycle to cycle. However, a
complete resistance towards ATP could not be
reached in A431 cells. A reduction of cell prolifera-
tion rate has been reported to lead to resistance to-
wards chemotherapeutic agents (i.e. [54]). After sev-
eral cycles of treatment with ATP, also the
morphology of A431 cells changed. Some of the
adapted cells resembled senescent ¢broblastic cells
which were enlarged showing £at pseudopodia [39].
Cellular senescence has also been discussed as a
mechanism of reduced sensitivity towards cytostatic
agents in cancer therapy. All phenotypic character-
istics of adaptation have been lost after several cell
divisions in the absence of ATP.
Response of intracellular Ca2 to ATP was
changed during the adaptation process. A431 control
cells responded to ATP (0.1 mM) with the increase of
free intracellular Ca2 in a biphasic manner, very
similar to the results reported by Gonzalez et al.
[40]. The rapid calcium increase peak (¢rst phase)
was unaltered, whereas the restoration (second
phase) was much shorter in adapted cells. The rele-
vance of the Ca2 response for the cytotoxic or
apoptotic mechanism of extracellular ATP has been
discussed controversially [55^58]. Several reports
have demonstrated the importance of the initial in-
crease of intracellular calcium in the signaling cas-
cade of apoptotic cell death triggered by ATP
[19,53,59]. However, the speci¢c receptor subtypes
(P2 or P1) and the further steps in the signaling cas-
cade that might be involved in ATP-mediated apop-
tosis have not been determined. A recently cloned
ATP-gated ion channel receptor subtype (P2x1) coded
by the RP-2 gene is upregulated in immature thymo-
cytes undergoing programmed cell death [60,61]. On
the other hand, adenosine has also been reported to
induce apoptosis in HL60 cells, either via P1 recep-
tors or via cellular uptake [62]. Our group has found
apoptosis to be triggered in U937 human histiocytic
lymphoma cells via the adenosine P1A3 receptor
(Schneider et al., unpublished data).
In our study, adapted A431 cells showed a clearly
shortened second phase of the Ca2 response. How-
ever, those cells still underwent apoptotic cell death
following ATP treatment. This may suggest an in-
triguing role of a maximum ¢rst Ca2 peak in cell
signaling which leads to apoptotic cell death in
A431 as shown in human breast cancer cells by Van-
dewalle et al. [19]. The mechanism of the shortened
calcium response in adapted cells is under current
investigation.
The adaptation process of A431 cells towards ATP
was accompanied by a marked simultaneous upregu-
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lation of the four ectonucleotidase activities deter-
mined in all adaptation protocols. The membrane-
bound ectoenzymes hydrolyzing extracellular nucleo-
tides (ATP, ADP, AMP, Ap4A) have not been iden-
ti¢ed and characterized before in A431 cells. Also for
other cells, there is no report on a simultaneous up-
regulation of these enzymes (ecto-ATPase, ecto-ADP-
ase, ecto-AMPase and ecto-Ap4Aase) under any
condition. The biochemical identi¢cation and char-
acterization of ectonucleotidases is still incomplete
[63]. Until now, there are no selective antibodies
available for the di¡erent ectonucleotidases to quan-
titate enzyme induction. However, when comparing
the extent of upregulation of enzyme activities in our
adapted cells (mcATP(2.0)), the calculated data
showed marked di¡erences between the single ecto-
nucleotidases. This suggests that the tentatively
named ecto-ATPase, ecto-ADPase, ecto-AMPase
(5P-nucleotidase) and ecto-Ap4Aase are distinct mem-
brane enzymes in A431 cells.
Ecto-ATPase has been discussed to serve as a pro-
tection mechanism from cytotoxic ATP in several cell
lines [26,64]. A quantitative correlation of protection
against ATP with enzyme activity has also been
documented in human cytotoxic lymphocytes [27].
In contrast to those ¢ndings, ATP-resistant cells
have been reported, which were not characterized
by an upregulated ecto-ATPase activity [62,65^67].
Only maximal velocity (Vmax) of the upregulated
ecto-ATPase activity was clearly altered whereas its
substrate a⁄nity (Km) remained constant. We there-
fore suggest that increased enzyme synthesis might
have occurred following ATP stimulation. However,
e¡ects on enzyme activity by activators, inhibitors or
enzyme modi¢cation cannot be excluded. The molec-
ular mechanisms triggering enzyme upregulation, ei-
ther receptor-mediated (P1 or P2) or induced by
adenosine uptake, remains to be elucidated.
The increased nucleotide metabolizing enzyme ac-
tivities induced by recurrent treatment of the cells
with ATP did not completely prevent the adapted
A431 cells from growth inhibition or apoptosis but
should be responsible for the reduced sensitivity of
A431 cells towards ATP.
The signi¢cance of the adaptive phenomena de-
scribed here under in vitro conditions should be tak-
en into account when applying ATP as a chemother-
apeutic substance for the treatment of cancer
patients.
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